Protalix Biotherapeutics Inc (PLX)
Equity Ratio
64.72%
Quarterly · Period ending:
PLX Equity Ratio
Latest reported64.72%period ending
Latest reported64.72%period ending
PLX Quarterly Equity Ratio (78.43% → 64.72%)
Latest values, visible window
High-resolution chart · PNG
PLX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 64.7151% | |
| 65.6944% | |
| 58.5699% | |
| 64.3149% | |
| 63.582% | |
| 61.1812% | |
| 58.8569% | |
| 52.6891% | |
| 31.2224% | |
| 33.16% | |
| 39.7577% | |
| 43.6764% | |
| 44.1103% | |
| 1.5144% | |
| -19.0725% | |
| -20.3037% | |
| -16.3077% | |
| -10.9459% | |
| -8.1939% | |
| 0.2551% | |
| 3.5498% | |
| 14.11% | |
| -39.7989% | |
| -46.0725% | |
| -48.4786% | |
| -37.2617% | |
| -154.9216% | |
| -131.8636% | |
| -122.1625% | |
| -98.0522% | |
| -86.5044% | |
| -96.7216% | |
| -95.8431% | |
| -60.8655% | |
| -43.3337% | |
| -42.6987% | |
| -35.0305% | |
| -95.2931% | |
| -12.1062% | |
| -21.4306% | |
| -10.1136% | |
| 3.0352% | |
| 11.1801% | |
| -115.16% | |
| -98.7613% | |
| -84.8795% | |
| -70.8564% | |
| -56.2462% | |
| -41.1687% | |
| -32.4689% | |
| -23.776% | |
| -13.7888% | |
| -19.2373% | |
| -8.9832% | |
| -4.2641% | |
| 6.1671% | |
| 9.327% | |
| -9.4312% | |
| -50.3368% | |
| -28.5275% | |
| -12.1063% | |
| 5.8142% | |
| -17.4929% | |
| -4.712% | |
| -2.0935% | |
| 9.2875% | |
| 16.0969% | |
| 78.9008% | |
| 82.7664% | |
| 85.7044% | |
| 87.2783% | |
| 90.3503% | |
| 91.4154% | |
| 92.2872% | |
| 93.4661% | |
| 84.1183% | |
| 88.4979% | |
| 90.9744% | |
| 89.9807% | |
| 98.5493% | |
| 98.5744% | |
| 93.956% | |
| 92.6136% | |
| 87.6563% | |
| 89.0974% | |
| 87.4802% | |
| 87.5452% | |
| 89.5809% | |
| 89.4237% | |
| 91.0758% | |
| 89.2649% | |
| 91.7343% | |
| 92.2438% | |
| 90.4021% | |
| 90.9652% | |
| 92.8272% | |
| 93.462% | |
| 92.8508% | |
| 92.4475% | |
| 88.2053% |